Xingshu Li
Fujian Provincial Key Laboratory Of Cancer Metastasis Chemoprevention And Chemotherapy
Fuzhou, 350108, China
Fuzhou, 350108, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Modulation of phthalocyanine assembly morphology for photodynamic therapy.
Journal: Chemical communications (Cambridge, England)
Published: November 19, 2025
Preparation and Performance of Phthalocyanine @ Copper Iodide Cluster Nanoparticles for X-Ray-Induced Photodynamic Therapy.
Journal: Molecules (Basel, Switzerland)
Published: September 23, 2025
Enhancing biosafety in photodynamic therapy: progress and perspectives.
Journal: Chemical Society reviews
Published: July 30, 2025
De Novo Construction of Glutathione Activatable Photosensitizers Boosts Sequential Photoacoustic and Fluorescence Imaging and Precise Photodynamic Therapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: May 21, 2025
A tumor-pH-responsive phthalocyanine as activatable type I photosensitizer for improved photodynamic immunotherapy.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: September 28, 2024
A Renal Clearable Nano-Assembly with Förster Resonance Energy Transfer Amplified Superoxide Radical and Heat Generation to Overcome Hypoxia Resistance in Phototherapeutics.
Journal: Angewandte Chemie (International ed. in English)
Published: June 19, 2024
Efficient hydroxyl radical generation of an activatable phthalocyanine photosensitizer: oligomer higher than monomer and nanoaggregate.
Journal: Chemical science
Published: April 02, 2024
Phthalocyanine aggregates as semiconductor-like photocatalysts for hypoxic-tumor photodynamic immunotherapy.
Journal: Nature communications
Published: February 29, 2024
A smart and visible way to switch the aromaticity of silicon(IV) phthalocyanines.
Journal: Chemical communications (Cambridge, England)
Published: July 28, 2023
A Sulfur-Bridging Sulfonate-Modified Zinc(II) Phthalocyanine Nanoliposome Possessing Hybrid Type I and Type II Photoreactions with Efficient Photodynamic Anticancer Effects.
Journal: Molecules (Basel, Switzerland)
Published: February 02, 2023
Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway.
Journal: Biomaterials research
Published: January 02, 2023
Last Updated: 09/26/2026